These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7779435)

  • 61. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
    Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
    J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Possible relationships between in vivo antitumour activity and toxicity of tumour necrosis factor-alpha.
    Palladino MA; Patton JS; Figari IS; Shalaby MR
    Ciba Found Symp; 1987; 131():21-38. PubMed ID: 3330012
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of photodynamic therapy on tumor oxygenation.
    Reed MW; Mullins AP; Anderson GL; Miller FN; Wieman TJ
    Surgery; 1989 Jul; 106(1):94-9. PubMed ID: 2525821
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Induction of tumour hypoxia by FAA and TNF: interaction with bioreductive drugs.
    Edwards HS; Bremner JC; Stratford IJ
    Int J Radiat Biol; 1991; 60(1-2):373-7. PubMed ID: 1677997
    [No Abstract]   [Full Text] [Related]  

  • 65. Do changes in tumor blood flow necessarily lead to changes in tissue oxygenation and in bioenergetic status?
    Vaupel P; Kelleher DK; Engel T
    Adv Exp Med Biol; 1994; 361():607-11. PubMed ID: 7597988
    [No Abstract]   [Full Text] [Related]  

  • 66. Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma.
    Pencavel TD; Wilkinson MJ; Mansfield DC; Khan AA; Seth R; Karapanagiotou EM; Roulstone V; Aguilar RJ; Chen NG; Szalay AA; Hayes AJ; Harrington KJ
    Int J Cancer; 2015 Feb; 136(4):965-76. PubMed ID: 24978211
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors.
    Horsman MR; Ehrnrooth E; Ladekarl M; Overgaard J
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):895-8. PubMed ID: 9845117
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alterations of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 alpha from murine alveolar macrophages.
    VanOtteren GM; Standiford TJ; Kunkel SL; Danforth JM; Strieter RM
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):399-409. PubMed ID: 7546769
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of tumor volume in 'reoxygenation' upon cyclophosphamide treatment.
    Busse M; Vaupel PW
    Acta Oncol; 1995; 34(3):405-8. PubMed ID: 7779431
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tocopherol in irradiation of temporary hypoxic tumours.
    Kågerud A; Lund N; Peterson HI
    Acta Radiol Oncol; 1981; 20(1):1-4. PubMed ID: 6264738
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Microregional blood flow in murine and human tumours assessed using laser Doppler microprobes.
    Hill SA; Pigott KH; Saunders MI; Powell ME; Arnold S; Obeid A; Ward G; Leahy M; Hoskin PJ; Chaplin DJ
    Br J Cancer Suppl; 1996 Jul; 27():S260-3. PubMed ID: 8763893
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression and purification of woodchuck tumour necrosis factor alpha.
    Lohrengel B; Lu M; Bauer D; Roggendorf M
    Cytokine; 2000 Jun; 12(6):573-7. PubMed ID: 10843731
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumour microenvironment and radiation response in sarcomas originating from tumourigenic human mesenchymal stem cells.
    D'Andrea FP; Safwat A; Burns JS; Kassem M; Horsman MR; Overgaard J
    Int J Radiat Biol; 2012 Jun; 88(6):457-65. PubMed ID: 22502876
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of tocopherol on tumour cell oxygenation.
    Kågerud A; Klintenberg C; Lund N; Peterson HI
    Cancer Lett; 1978 Oct; 5(4):185-9. PubMed ID: 688200
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The relationship between carbon monoxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo.
    Grau C; Khalil AA; Nordsmark M; Horsman MR; Overgaard J
    Br J Cancer; 1994 Jan; 69(1):50-7. PubMed ID: 8286210
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of an hypoxic cell sensitizer on tumour growth delay and cell survival. Implications for cell survival in situ and in vitro.
    McNally NJ
    Br J Cancer; 1975 Nov; 32(5):610-8. PubMed ID: 1212418
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of hypoxia and glucose deprivation on tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor expression in human cultured monocytes.
    Guida E; Stewart A
    Cell Physiol Biochem; 1998; 8(1-2):75-88. PubMed ID: 9547021
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lack of association between tumor oxygenation and cell cycle distribution or proliferation kinetics in experimental sarcomas.
    Thews O; Kelleher DK; Vaupel P
    Adv Exp Med Biol; 2003; 540():245-50. PubMed ID: 15174626
    [No Abstract]   [Full Text] [Related]  

  • 79. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human TNF mutants with selective activity on the p55 receptor.
    Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W
    Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.